» Articles » PMID: 14699148

Poly(ADP-ribose) Reactivates Stalled DNA Topoisomerase I and Induces DNA Strand Break Resealing

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2003 Dec 31
PMID 14699148
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Regulating the topological state of DNA is a vital function of the enzyme DNA topoisomerase I. However, when acting on damaged DNA, topoisomerase I may get trapped in a covalent complex with nicked DNA (stalled topoisomerase I), that, if unrepaired, may lead to genomic instability or cell death. Here we show that ADP-ribose polymers target specific domains of topoisomerase I and reprogram the enzyme to remove itself from cleaved DNA and close the resulting gap. Two members of the poly(ADP-ribose) polymerase family, PARP-1 and 2, act as poly(ADP-ribose) carriers to stalled topoisomerase I sites and induce efficient repair of enzyme-associated DNA strand breaks. Thus, by counteracting topoisomerase I-induced DNA damage, PARP-1 and PARP-2 act as positive regulators of genomic stability in eukaryotic cells.

Citing Articles

Preclinical evaluation of a novel antibody-drug conjugate OBI-992 for Cancer therapy.

Chang T, Lin C, Wen S, Wu Y, Wei C, Huang J Sci Rep. 2025; 15(1):8735.

PMID: 40082588 PMC: 11906863. DOI: 10.1038/s41598-025-92697-z.


ATR safeguards replication forks against APOBEC3B-induced toxic PARP1 trapping.

Ortega P, Bournique E, Li J, Sanchez A, Santiago G, Harris B bioRxiv. 2024; .

PMID: 39605722 PMC: 11601322. DOI: 10.1101/2024.11.14.623607.


PARP1-dependent DNA-protein crosslink repair.

Fabian Z, Kakulidis E, Hendriks I, Kuhbacher U, Larsen N, Oliva-Santiago M Nat Commun. 2024; 15(1):6641.

PMID: 39103378 PMC: 11300803. DOI: 10.1038/s41467-024-50912-x.


Specific and shared biological functions of PARP2 - is PARP2 really a lil' brother of PARP1?.

Szanto M, Yelamos J, Bai P Expert Rev Mol Med. 2024; 26:e13.

PMID: 38698556 PMC: 11140550. DOI: 10.1017/erm.2024.14.


Unveiling the vulnerabilities of synthetic lethality in triple-negative breast cancer.

Chatterjee P, Karn R, Isaac A, Ray S Clin Transl Oncol. 2023; 25(11):3057-3072.

PMID: 37079210 DOI: 10.1007/s12094-023-03191-9.